Featured post

A Highly Pathogenic #Avian #H7N9 #Influenza Virus Isolated from A #Human Is Lethal in Some #Ferrets Infected via #Respiratory #Droplets (Cell Host Microbe, abstract)

Title : A Highly Pathogenic #Avian #H7N9 #Influenza Virus Isolated from A #Human Is Lethal in Some #Ferrets Infected via #Respiratory #Drop...

20 Oct 2012

Research Articles Abstracts – October 20 2012 Issue

[Source: AMEDEO, homepage: (LINK).]

Research Articles Abstracts – October 20 2012 Issue


Abstracts List

  1. Ackerman S, Gonzales R.
  2. Hebert C, Beaumont J, Schwartz G, Robicsek A, et al.
    • The influence of context on antimicrobial prescribing for febrile respiratory illness: a cohort study.
  3. Serebryakova MV, Kordyukova LV, Rudneva IA, Kropotkina EA, et al.
    • Mass spectrometry analysis of influenza virus reassortant clones does not reveal an influence of other viral proteins on S-acylation of hemagglutinin.
  4. Dyer C.
    • Catalogue of failures at Manchester hospital contributed to disabled girl's death.
  5. Yan X, Wang Q, Zhang Z, Xie Y, et al.
    • Involvement of non-structural proteins (NS) in influenza A infection and viral tropism.
      • Biochem Biophys Res Commun. 2012 Oct 8. pii: S0006-291X(12)01930.  
      • PubMed
      • Related Articles
      • Abstract available
  6. Wongphatcharachai M, Wang P, Enomoto S, Webby RJ, et al.
    • Neutralizing DNA Aptamers Against Swine Influenza H3N2 Viruses.
  7. Tang YW, Lowery KS, Valsamakis A, Schaefer VC, et al.
    • Validation of a PLEX-ID Flu Device for Simultaneous Detection and Identification of Influenza Viruses A and B.
  8. Mooney AJ, Li Z, Gabbard JD, He B, et al.
    • Recombinant PIV5 vaccine encoding the influenza hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
  9. Xie H, Lin Z, Mosier PD, Desai UR, et al.
    • The Compensatory G88R Change is Essential in Restoring the Normal Functions of Influenza A/WSN/33 Viral Matrix Protein 1 with Disrupted Nuclear Localization Signal.
  10. Li Z, Mooney A, Gabbard JD, Gao X, et al.
    • Recombinant Parainfluenza Virus 5 Expressing HA Of Influenza A Virus H5N1 Protected Mice Against Lethal High Pathogenic Avian Influenza H5N1 Challenge.
  11. Moncorge O, Long JS, Cauldwell AV, Zhou H, et al.
    • Investigation of influenza polymerase activity in pig cells.
  12. Bottcher-Friebertshauser E, Lu Y, Meyer D, Sielaff F, et al.
    • Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
  13. Ahmed SS, Themudo GE, Christensen JP, Biswas PK, et al.
    • Molecular epidemiology of circulating highly pathogenic avian influenza (H5N1) virus in chickens, in Bangladesh, 2007-2010.
  14. Wasilewski S, Calder LJ, Grant T, Rosenthal PB, et al.
    • Distribution of surface glycoproteins on influenza A virus determined by electron cryotomography.
  15. Fournier E, Moules V, Essere B, Paillart JC, et al.
    • Interaction network linking the human H3N2 influenza A virus genomic RNA segments.
  16. Kiseleva I, Dubrovina I, Bazhenova E, Fedorova E, et al.
    • Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains.
  17. Osterhaus AD.
    • Scientists and policy makers gathered in the post H1N1 pandemic period at the Fourth ESWI Influenza Conference.
  18. Maraskovsky E, Rockman S, Dyson A, Koernig S, et al.
    • Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.
  19. Avilov SV, Moisy D, Naffakh N, Cusack S, et al.
    • Influenza A virus progeny vRNP trafficking in live infected cells studied with the virus-encoded fluorescently tagged PB2 protein.
  20. Gerlach T, Kuhling L, Uhlendorff J, Laukemper V, et al.
    • Characterization of the neuraminidase of the H1N1/09 pandemic influenza virus.
  21. Esposito S, Marchisio P, Montinaro V, Bianchini S, et al.
    • The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged >/=6 to <36 months: Data from a randomized, Phase III study.
  22. Sun Y, Sun S, Ma J, Tan Y, et al.
    • Identification and characterization of avian-origin H3N2 canine influenza viruses in northern China during 2009-2010.